The ASX has had a stellar trading week, setting five new intraday highs and closing out on a new record above 8930 points.
Lion Selection Group’s Hedley Widdup says the humble developers have been the standout gold stock class of 2025 so far.
Another explorer is hot on the trail of the next DeGrussa, as excitement returns to the birthplace of ASX copper legend Sandfire.
The ASX healthcare sector, up over the past five days, has had a “reasonable start” to reporting season, notes Morgans’ Scott Power.
Neurizon Therapeutics’ drug candidate NUZ-001 FDA review to lift the clinical hold has been delayed until October 3rd.
Jack Zhang has warned staff to use AI daily or risk unemployment. CBA’s Matt Comyn agrees. So is your job on the line, and how can you turn it around?
